Strength
750 mg/1
Manufacturer
McKessonNDC
63739099210
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
METHOCARBAMOLApproval Type
Generic (ANDA)
FDA Application
ANDA209312On Market Since
7/22/2021
Pharmacological Classes
Price Statistics
The NADAC for METHOCARBAMOL 750 MG TABLET has been published 231 times since Nov 3, 2021, and over the history we have for it it has declined 53.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0435 per EA |
|---|---|
| All-time high | $0.0931 (Apr 13, 2022) |
| All-time low | $0.0346 (Jul 17, 2024) |
| 52-week high | $0.0445 |
| 52-week low | $0.0433 |
| Median price | $0.0474 |
| Average price | $0.0514 |
| Largest weekly change | +34.4% (Aug 21, 2024) |
| Weeks tracked | 231 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHOCARBAMOL 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOCARBAMOL 750 MG TABLET, manufactured by McKesson, is $0.0435 per EA (NDC 63739099210), effective Apr 1, 2026.
How has the price of METHOCARBAMOL 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOCARBAMOL 750 MG TABLET has declined 53.0%. It has been tracked across 231 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for METHOCARBAMOL 750 MG TABLET?
Since Nov 3, 2021, the NADAC for METHOCARBAMOL 750 MG TABLET has ranged from a low of $0.0346 (Jul 17, 2024) to a high of $0.0931 (Apr 13, 2022), with a median of $0.0474 per EA.
Are there cheaper alternatives to METHOCARBAMOL 750 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, METHOCARBAMOL 750 MG TABLET, is $0.0429 per EA — about 2% below METHOCARBAMOL 750 MG TABLET.
Who manufactures METHOCARBAMOL 750 MG TABLET?
METHOCARBAMOL 750 MG TABLET (NDC 63739099210) is labeled by McKesson, and CMS classifies it as a generic product.
Related Drugs
Same classification